Node-Positive Breast Cancer: Which Are the Best Chemotherapy Regimens?

Publisher： Karger

E-ISSN： 1661-3805|3|4|244-250

ISSN： 1661-3791

Source： Breast Care, Vol.3, Iss.4, 2008-08, pp. : 244-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Node-Negative Breast Cancer: Which Patients Should Be Treated?

By  

Breast Care, Vol. 3, Iss. 4, 2008-08 ,pp. : 237-243

Karger

Access to resources Recommend Favorite

Effectiveness of Pertuzumab, Trastuzumab, and Docetaxel Combination Neoadjuvant Chemotherapy for HER2-Positive Inflammatory Breast Cancer: A Case Report

By  

Breast Care, Vol. 12, Iss. 1, 2017-02 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

Chemotherapy in Premenopausal Breast Cancer Patients

By  

Breast Care, Vol. 10, Iss. 5, 2015-0 ,pp. : 307-310

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Primary Breast Cancer

By  

Breast Care, Vol. 1, Iss. 4, 2006-09 ,pp. : 238-241

Karger

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Operable Breast Cancer: The Pros

By  

Breast Care, Vol. 1, Iss. 6, 2006-12 ,pp. : 348-351

Karger

Access to resources Recommend Favorite